Sports cardiology has undergone major developments [1]. From the pre-participation assessment of athletes to risk stratification of individuals with cardiovascular disease (CVD), this field comprises a core component of cardiovascular medicine [2]. Inputs from areas such as genetics, non-invasive imaging, or invasive haemodynamic studies have provided insights into the association between cardiovascular physiology and exercise [2,3]. Given its availability, cost, portability, safety (namely absence of ionizing radiation), and versatility (allowing both rest and exercise workflows, and integration with other techniques), echocardiography stands as an important exam in sports cardiology, providing a comprehensive assessment of cardiovascular morphology and function (Fig. 1) [3,4,5].
Fig. 1.
General outline of some of the main applications of echocardiography in sports cardiology. Echocardiography has a leading role in sports cardiology, as part of comprehensive workflows. These may include distinguishing between exercise-induced cardiac remodeling and pathology (particularly early-stage cardiomyopathies), and risk stratification of individuals with cardiovascular disease prior to exercise training. Some features of interest include chamber dimensions and wall thickness, aortic dimensions, valvular morphology and haemodynamic characteristics, or systolic and diastolic function (using a multiparametric approach across the examination). Both resting and stress (exercise) echocardiography can provide important data, the latter allowing an overview of the cardiovascular response to exercise. These should be analysed in view of the individual’s clinical history and physical examination, as well as other diagnostic tests (such as the electrocardiogram, but also other ancillary modalities according to the clinical context).
1. Exercise and the Cardiovascular System
Exercise may lead to several cardiovascular adaptations (classically described as the “athlete’s heart”) ranging from those on molecular and electrical levels, to functional and structural changes [1,3,6,7,8,9]. Different types of exercise impose a distinct burden on the cardiovascular system [3,10]. Although strict dichotomic classifications of endurance (isotonic) versus strength (isometric) training have major limitations, adaptations tend to be more prominent in sports with a pronounced endurance component, such as cycling or rowing [2,3,10]. These reflect the sustained increase in cardiac output (CO) with reduced or normal peripheral vascular resistance (PVR), whereas isometric training is characterized by slightly elevated or normal CO alongside significant (but typically transient) increases in PVR [5]. In this regard, harmonic dilatation of cardiac chambers, increases in left ventricle (LV) mass, and enhanced early diastolic filling (typically with a prominent E wave and an E/A ratio >2) have been reported [3,6,10,11]. These changes enable increases in stroke volume, addressing the need for higher CO coupled to improved performance [3,12,13]. Some adaptations, however, may lead to difficulties in phenotypic classification, namely with entities such as cardiomyopathies [14,15]. While not recommended for universal first-line screening of athletes, echocardiography is nonetheless pivotal when determining the degree of CVD [2,15,16].
2. Exercise-Induced Cardiac Remodeling and Differential Diagnosis
When differentiating physiological exercise-induced cardiac remodeling (EICR) from pathology, integrated frameworks are essential (Supplementary Fig. 1) [3,14,15,17]. Cardiovascular symptoms, such as chest pain or syncope with exertion, and physical examination abnormalities warrant further investigation [1,4]. Prior family history and electrocardiographic features also provide valuable information [1,17]. Furthermore, EICR may be influenced by age, sex, ethnicity, anthropometric data, training history, and the use of performance-enhancing or pharmacological agents [1,3,18,19].
Cardiac chamber dilatation is a hallmark of EICR [3,14]. Nonetheless, particularly in those with reduced left ventricular ejection fraction (LVEF), the presence of other entities such as dilated or arrhythmogenic cardiomyopathy may present challenges [1,14,20]. First, as stated above, clinical status and training history should be ascertained [1]. Second, unbalanced chamber dilatations (namely isolated right or LV dilatation) or findings such as complex ventricular ectopy or elevated natriuretic peptides, should prompt consideration of an underlying pathology [11,15,17,20]. Though applying specific cut-offs for LV dimensions is discouraged, evidence suggests that indexing dimensions to functional capacity may better reflect cardiac adaptations [3,12,15,21]. Interestingly, this indexing may also be relevant when assessing blood pressure, particularly in the context of hypertensive responses to exercise [22]. Finally, some highly conditioned athletes may exhibit a resting LVEF slightly below or close to the lower limit of normal. However, marked reductions in LVEF (particularly <45%) or impaired LV global longitudinal strain raise the possibility of disease [1,15,19,23]. Exercise stress echocardiography (ESE) can be useful in borderline cases, as an increase in LVEF (with cut-offs >11% and peak LVEF >63% having been described) supports physiological adaptations [1,4,20].
Slight increases in LV mass are also a feature of EICR [3,10,15]. These conditions optimize cardiac mechanics, thereby limiting excessive LV wall stress as this chamber dilates [10]. While acknowledging variations due to several factors (including sex and ethnicity, with higher values reported for male patients and those of African ancestry), marked LV hypertrophy (particularly LV wall thickness >15 mm) or asymmetric patterns should raise suspicion for hypertrophic cardiomyopathy (HCM) [1,3,6]. As previously noted, supranormal LV diastolic function is a feature seen in EICR [11]. Although E/A ratios and left atrial dimensions present pitfalls (with increases potentially linked to EICR), e’ and E/e’ may be useful when distinguishing physiological adaptations from pathology [11,14]. Despite their potential, current guidance does not include left atrial strain parameters in this context [11,15,23].
3. Risk Stratification—Focus on a Personalized Approach
An important application of echocardiography involves risk stratification prior to exercise training, where both resting and ESE can be of value [1,2,3,4,24,25,26,27]. While past paradigms were relatively restrictive, namely in settings such as HCM or congenital heart disease (CHD), current guidance supports personalized approaches on a background of shared decision-making [2,24]. Parameters such as LV systolic function are crucial when assessing patients with conditions ranging from chronic coronary syndromes to CHD [2]. This is also the case in valvular heart disease (VHD), where echocardiography provides data concerning morphology, functional status, and signs of extravalvular cardiac disease [2,24,28]. A thorough assessment is essential in arrhythmias to identify structural heart disease [2,24].
Regarding ESE, applications include analysing obstruction in HCM (with both diagnostic and prognostic value) or ischaemia in congenital abnormalities of the coronary arteries, myocardial bridging, or those with suspected chronic coronary syndromes [2,5,24,25,26]. As discussed in the current guidelines, ESE may also be valuable in VHD, namely in asymptomatic patients or in cases of mismatch between symptoms and resting findings [28]. By using exercise as a stressor (as opposed to drugs), ESE can be particularly useful in these settings to reproduce the physiological response to exertion, while data attests to its safety [2,5,19,27]. Beyond imaging, data concerning symptoms, functional capacity, blood pressure, and arrhythmias during ESE provide critical inputs for clinical decision-making [2,5,25,26].
4. Current Paradigms and Future Directions
Sports cardiology has evolved into a broad field, and several concepts derived from the cardiovascular response to exercise have extensive applications across the cardiovascular continuum [1,2,3,4,5,24,26,28]. As a highly adaptable test, echocardiography stands as a cornerstone in this field, assisting in harnessing the benefits of exercise while mitigating risks [2,3,4,5]. Whilst acknowledging limitations such as optimal pre-participation workflows or the long-term significance of findings such as LV dilatation, new developments continue to expand on previous results [16,17,29]. Notably, while addressing pitfalls such as validation, standardization, and population representation, artificial intelligence-assisted image interpretation could further streamline results, with deep learning techniques enhancing data integration [30]. As our understanding of the complex interaction between exercise and the cardiovascular system continues to advance, echocardiography is set to remain at the forefront of this challenging field.
Acknowledgment
Not applicable.
Abbreviations
CO, cardiac output; CVD, cardiovascular disease; CHD, congenital heart disease; EF, ejection fraction; EICR, exercise-induced cardiac remodeling; ESE, exercise stress echocardiography; HCM, hypertrophic cardiomyopathy; LV, left ventricle; LVEF, left ventricular ejection fraction; PVR, peripheral vascular resistance; VHD, valvular heart disease.
Funding Statement
This research received no external funding.
Footnotes
Publisher’s Note: IMR Press stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Author Contributions
EMV: design of research study, research and data analysis, manuscript writing. FS, JR, RFC: research and data analysis, manuscript writing, critical revision of manuscript. All authors contributed to editorial changes in the manuscript. All authors read and approved the final manuscript. All authors have participated sufficiently in the work and agreed to be accountable for all aspects of the work.
Ethics Approval and Consent to Participate
Not applicable.
Funding
This research received no external funding.
Conflicts of Interest
The authors declare no conflicts of interest.
Supplementary Material
Supplementary material associated with this article can be found, in the online version, at https://doi.org/10.31083/RCM53090.
References
- [1].Sharma S, Marwaha S. Sports cardiology for the general cardiologist. Heart. 2026 doi: 10.1136/heartjnl-2025-326963. (online ahead of print) [DOI] [PubMed] [Google Scholar]
- [2].Pelliccia A, Sharma S, Gati S, Bäck M, Börjesson M, Caselli S, et al. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease. European Heart Journal. 2021;42:17–96. doi: 10.1093/eurheartj/ehaa605. [DOI] [PubMed] [Google Scholar]
- [3].Baggish AL, Battle RW, Beaver TA, Border WL, Douglas PS, Kramer CM, et al. Recommendations on the Use of Multimodality Cardiovascular Imaging in Young Adult Competitive Athletes: A Report from the American Society of Echocardiography in Collaboration with the Society of Cardiovascular Computed Tomography and the Society for Cardiovascular Magnetic Resonance. Journal of the American Society of Echocardiography. 2020;33:523–549. doi: 10.1016/j.echo.2020.02.009. [DOI] [PubMed] [Google Scholar]
- [4].Cavarretta E, D'Ascenzi F, Bianco M, Castelletti S, Cavigli L, Cecchi F, et al. The role of echocardiography in sports cardiology: An expert opinion statement of the Italian Society of Sports Cardiology (SIC sport) International Journal of Cardiology. 2024;410:132230. doi: 10.1016/j.ijcard.2024.132230. [DOI] [PubMed] [Google Scholar]
- [5].Vilela EM, Sampaio F, Ribeiro J, Fontes-Carvalho R. Exercise Stress Echocardiography: A Dynamic Assessment for an Evolving Landscape. Reviews in Cardiovascular Medicine. 2026;27:47079. doi: 10.31083/RCM47079. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [6].Hsieh PN, Shen S, Chukwurah MI, Churchill TW, Stewart KM, Chung EH, et al. Athlete's Heart Revisited: Historical, Clinical, and Molecular Perspectives. Circulation Research. 2025;137:231–254. doi: 10.1161/CIRCRESAHA.125.325638. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [7].Fontes-Carvalho R, Vilela EM, Gonçalves-Teixeira P. The effect of exercise training in systolic and diastolic function. In: Watson RR, Zibadi S, editors. Lifestyle in Heart Health and Disease. 1st edn. Elsevier; Netherlands: 2018. pp. 153–162. [Google Scholar]
- [8].Vilela EM, Fontes-Carvalho R. Mecânica Ventricular Esquerda: Desvendando as Vias da Resposta Cardiovascular ao Exercício. Arquivos Brasileiros De Cardiologia. 2023;120:e20230181. doi: 10.36660/abc.20230181. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [9].Carbone A, Monda E, Ferrara F, Franzese M, Bottino R, Russo V, et al. Aortic Dimension in Elite Athletes: Updated Systematic Review and Meta-Analysis. European Journal of Preventive Cardiology. 2024 doi: 10.1093/eurjpc/zwae385. (online ahead of print) [DOI] [PubMed] [Google Scholar]
- [10].Pelliccia A, Caselli S. Structural and functional adaptations in the athlete's heart. In: Pelliccia A, Heidbuchel H, Corrado D, Börjesson M, Sharma S, editors. The ESC Textbook of Sports Cardiology. 1st edn. Oxford University Press; United Kingdom: 2019. pp. 9–20. [Google Scholar]
- [11].Dalen H, Letnes JM, Hoydal MA, Wisløff U. Diastolic function and dysfunction in athletes. European Heart Journal. Cardiovascular Imaging. 2024;25:1537–1545. doi: 10.1093/ehjci/jeae155. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [12].Hofbauer T, Heber S, Schöny H, Ritter H, Wessner B, Scharhag J. The Recreational Athlete's Heart: Sex-Specific Three-Dimensional Echocardiographic Reference Values in Relation to V̇O2peak. European Journal of Preventive Cardiology. 2025 doi: 10.1093/eurjpc/zwaf758. (online ahead of print) [DOI] [PubMed] [Google Scholar]
- [13].Ferrera A, Di Gioia G, Daniello CD, Paoletti G, Spera FR, Mango F, et al. Echocardiographic morpho-functional parameters predictors of maximal oxygen uptake and oxygen pulse in a large cohort of elite athletes practicing different sporting disciplines. International Journal of Cardiology. 2026;450:134233. doi: 10.1016/j.ijcard.2026.134233. [DOI] [PubMed] [Google Scholar]
- [14].Fritzlen JT, Martinez MW. Echocardiography in Athletes: the Ever-Evolving Assessment of Physiology Versus Pathology. Current Cardiology Reports. 2026;28:12. doi: 10.1007/s11886-025-02327-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [15].Oxborough D, George K, Cooper R, Bhatia R, Ramcharan T, Zaidi A, et al. Echocardiography in the cardiac assessment of young athletes: a 2025 guideline from the British Society of Echocardiography (endorsed by Cardiac Risk in the Young) Echo Research and Practice. 2025;12:7. doi: 10.1186/s44156-025-00069-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [16].Baggish AL, Borjesson M, Pieles GE, Schmied C, Colombo CSSDS, Gonzales Corcia C, et al. Recommendations for cardiac screening and emergency action planning in youth football: a FIFA consensus statement. British Journal of Sports Medicine. 2025;59:751–760. doi: 10.1136/bjsports-2025-109751. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [17].Finocchiaro G, Zorzi A, Abela M, Baggish A, Castelletti S, Cavarretta E, et al. Abnormal electrocardiogram findings in athletes. European Heart Journal. 2026;47:152–169. doi: 10.1093/eurheartj/ehaf646. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [18].Maestrini V, Squeo MR, Monosilio S. The challenge of interpreting cardiac adaptation to exercise: the importance of picking up the training history. European Heart Journal. 2025;46:187–189. doi: 10.1093/eurheartj/ehae535. [DOI] [PubMed] [Google Scholar]
- [19].Phelan DM, Claessen G, Eijsvogels TMH, Churchill TW, Dineen EH, Gati S, et al. Cardiovascular Imaging Considerations for Masters-Aged Athletes. JACC. Cardiovascular Imaging. 2026;19:538–550. doi: 10.1016/j.jcmg.2025.10.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [20].Millar LM, Fanton Z, Finocchiaro G, Sanchez-Fernandez G, Dhutia H, Malhotra A, et al. Differentiation between athlete's heart and dilated cardiomyopathy in athletic individuals. Heart. 2020;106:1059–1065. doi: 10.1136/heartjnl-2019-316147. [DOI] [PubMed] [Google Scholar]
- [21].Schellenberg J, Matits L, Kersten J, Bizjak DA, Kirsten J, Fremo T, et al. Physiological assessment of left ventricular size indexed by peak oxygen uptake across sporting disciplines. European Heart Journal. Imaging Methods and Practice. 2025;3:qyaf138. doi: 10.1093/ehjimp/qyaf138. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [22].Schultz MG, Otahal P, Roberts-Thomson P, Stanton T, Hamilton-Craig C, Wahi S, et al. Exercise blood pressure relative to fitness and cardiovascular outcomes: the EXERTION study. European Heart Journal. 2026;47:1661–1671. doi: 10.1093/eurheartj/ehaf1082. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [23].Thomas JD, Edvardsen T, Abraham T, Appadurai V, Badano L, Banchs J, et al. Clinical Applications of Strain Echocardiography: A Clinical Consensus Statement From the American Society of Echocardiography Developed in Collaboration With the European Association of Cardiovascular Imaging of the European Society of Cardiology. Journal of the American Society of Echocardiography. 2025;38:985–1020. doi: 10.1016/j.echo.2025.07.007. [DOI] [PubMed] [Google Scholar]
- [24].Kim JH, Baggish AL, Levine BD, Ackerman MJ, Day SM, Dineen EH, et al. Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities: A Scientific Statement From the American Heart Association and American College of Cardiology. Circulation. 2025;151:e716–e761. doi: 10.1161/CIR.0000000000001297. [DOI] [PubMed] [Google Scholar]
- [25].Sultana S, Jadam S, Abusafia M, Gaballa A, Ospina S, Rutkowski K, et al. Treadmill Stress Echocardiography in Hypertrophic Cardiomyopathy: Ascertaining True Asymptomatic Status and Long-Term Prognosis. JACC. Cardiovascular Imaging. 2026;19:561–564. doi: 10.1016/j.jcmg.2025.11.001. [DOI] [PubMed] [Google Scholar]
- [26].Cardim N, Haugaa K, Mohiddin SA, Hinojar R, Hirsch A, Szabo L, et al. Role of multi-modality cardiac imaging in the management of patients with hypertrophic cardiomyopathy in 2025. A Clinical Consensus Statement of the European Association of Cardiovascular Imaging (EACVI) of the ESC. European Heart Journal. Cardiovascular Imaging. 2026;27:369–399. doi: 10.1093/ehjci/jeaf282. [DOI] [PubMed] [Google Scholar]
- [27].Lee C, Dow S, Shah K, Henkin S, Taub C. Complications of exercise and pharmacologic stress echocardiography. Frontiers in Cardiovascular Medicine. 2023;10:1228613. doi: 10.3389/fcvm.2023.1228613. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [28].Praz F, Borger MA, Lanz J, Marin-Cuartas M, Abreu A, Adamo M, et al. 2025 ESC/EACTS Guidelines for the management of valvular heart disease. European Heart Journal. 2025;46:4635–4736. doi: 10.1093/eurheartj/ehaf194. [DOI] [PubMed] [Google Scholar]
- [29].Claessen G, De Bosscher R, Janssens K, Young P, Dausin C, Claeys M, et al. Reduced Ejection Fraction in Elite Endurance Athletes: Clinical and Genetic Overlap With Dilated Cardiomyopathy. Circulation. 2024;149:1405–1415. doi: 10.1161/CIRCULATIONAHA.122.063777. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [30].Palermi S, Vecchiato M, Saglietto A, Niederseer D, Oxborough D, Ortega-Martorell S, et al. Unlocking the potential of artificial intelligence in sports cardiology: does it have a role in evaluating athlete's heart? European Journal of Preventive Cardiology. 2024;31:470–482. doi: 10.1093/eurjpc/zwae008. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.

